Science Explorer Back to mapMap
Discussion
Company · Dongguan · China

HEC Pharm (China)

hecpharm.comROR OpenAlex
Research works
97
▲ 24% vs 2018-21
Citations
1.2k
12.2 per fractional work
Top-10% rate
6.9%
all institutions 10.0%
Open access
30%
world 40%
International
10%
world 18%
HEC Pharm (China)

Not ranked overall: HEC Pharm (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does HEC Pharm (China) work in?

In 2022-now, 40% of research at HEC Pharm (China) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (40%), Biochemistry, Genetics and Molecular Biology (19%), Chemistry (18%). It does 1.9× the world's share of Life Sciences.

Health Sciences: 19 fractional works · 40.3% of its workMedicine: 18 fractional works · 39.9% of its workOncology: 2 fractional works · 5.2% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 4.7% of its workEpidemiology: 2 fractional works · 4.0% of its workPharmacology: 2 fractional works · 3.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.0% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.5% of its workSurgery: 1 fractional works · 2.0% of its workPhysiology: 1 fractional works · 1.7% of its workComplementary and alternative medicine: 1 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.5% of its workBiochemistry: 1 fractional works · 1.1% of its workGastroenterology: 0 fractional works · 1.1% of its workHepatology: 0 fractional works · 1.0% of its workInfectious Diseases: 0 fractional works · 0.9% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.7% of its workRheumatology: 0 fractional works · 0.7% of its workNephrology: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.4% of its workEmergency Medicine: 0 fractional works · 0.2% of its workRehabilitation: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workLife Sciences: 14 fractional works · 30.2% of its workBiochemistry, Genetics and Molecular Biology: 9 fractional works · 19.5% of its workMolecular Biology: 7 fractional works · 15.2% of its workBiochemistry: 1 fractional works · 1.3% of its workGenetics: 0 fractional works · 1.1% of its workBiotechnology: 0 fractional works · 0.8% of its workCell Biology: 0 fractional works · 0.5% of its workCancer Research: 0 fractional works · 0.4% of its workMolecular Medicine: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 2 fractional works · 4.6% of its workFood Science: 1 fractional works · 2.2% of its workAquatic Science: 0 fractional works · 0.9% of its workPlant Science: 0 fractional works · 0.8% of its workAnimal Science and Zoology: 0 fractional works · 0.7% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 3.8% of its workPharmacology: 1 fractional works · 2.2% of its workPharmaceutical Science: 1 fractional works · 1.6% of its workNeuroscience: 1 fractional works · 1.2% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.2% of its workImmunology and Microbiology: 0 fractional works · 1.1% of its workImmunology: 0 fractional works · 1.1% of its workPhysical Sciences: 14 fractional works · 29.5% of its workChemistry: 8 fractional works · 18.3% of its workOrganic Chemistry: 4 fractional works · 8.1% of its workSpectroscopy: 3 fractional works · 5.6% of its workAnalytical Chemistry: 2 fractional works · 3.6% of its workElectrochemistry: 0 fractional works · 0.5% of its workInorganic Chemistry: 0 fractional works · 0.5% of its workMaterials Science: 2 fractional works · 4.3% of its workMaterials Chemistry: 1 fractional works · 2.8% of its workPolymers and Plastics: 0 fractional works · 0.7% of its workBiomaterials: 0 fractional works · 0.5% of its workSurfaces, Coatings and Films: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 1 fractional works · 2.3% of its workBiomedical Engineering: 1 fractional works · 1.2% of its workElectrical and Electronic Engineering: 0 fractional works · 0.9% of its workMechanical Engineering: 0 fractional works · 0.2% of its workEnergy: 1 fractional works · 1.5% of its workRenewable Energy, Sustainability and the Environment: 1 fractional works · 1.5% of its workEnvironmental Science: 0 fractional works · 1.0% of its workEcology: 0 fractional works · 0.6% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 1.0% of its workProcess Chemistry and Technology: 0 fractional works · 0.7% of its workCatalysis: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.7% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workALL ITS WORKHEC Pharm (China)46fractional works, 2022-now
Life Sciences30%Physical Sciences29%Health Sciences40%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 15 fields, with their numbers
    1. Medicine1839.9%
    2. Nursing00.5%
    1. Biochemistry, Genetics and Molecular Biology919.5%
    2. Agricultural and Biological Sciences24.6%
    3. Pharmacology, Toxicology and Pharmaceutics23.8%
    4. Neuroscience11.2%
    5. Immunology and Microbiology01.1%
    1. Chemistry818.3%
    2. Materials Science24.3%
    3. Engineering12.3%
    4. Energy11.5%
    5. Environmental Science01.0%
    6. Chemical Engineering01.0%
    7. Computer Science00.7%
    8. Mathematics00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.96× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.65× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 1.08× its world share, 0 worksImmunology and Micro…Neuroscience: 0.74× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.78× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 2.76× its world share, 0 worksChemical EngineeringChemistry: 11.66× its world share, 8 worksChemistryComputer Science: 0.10× its world share, 0 worksComputer ScienceEnergy: 1.64× its world share, 1 worksEnergyEngineering: 0.15× its world share, 1 worksEngineeringEnvironmental Science: 0.21× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.23× its world share, 2 worksMaterials ScienceMathematics: 0.31× its world share, 0 worksMathematicsMedicine: 2.07× its world share, 18 worksMedicineNursing: 0.95× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 11.7×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Chemistry11.66×8 works
  2. Pharmacology, Toxicology and Pharmaceutics10.78×2 works
  3. Biochemistry, Genetics and Molecular Biology3.65×9 works
  4. Chemical Engineering2.76×0 works
  5. Medicine2.07×18 works
  6. Energy1.64×1 works
  7. Materials Science1.23×2 works
  8. Immunology and Microbiology1.08×0 works
  9. Agricultural and Biological Sciences0.96×2 works
  10. Nursing0.95×0 works
  11. Neuroscience0.74×1 works
  12. Mathematics0.31×0 works
  13. Environmental Science0.21×0 works
  14. Engineering0.15×1 works
  15. Computer Science0.10×0 works

Who are the top researchers at HEC Pharm (China)?

Ranked on the quality score, Zhonghua Luo, Zhongqing Wang and Chuanfei Jin lead among researchers whose main affiliation is HEC Pharm (China).

  1. 1 Zhonghua Luo China · #4,328,904 worldwide 297 citations · 16 works
  2. 2 Zhongqing Wang China · #5,364,236 worldwide 593 citations · 67 works
  3. 3 Chuanfei Jin China · #5,532,404 worldwide 322 citations · 29 works
  4. 4 Shuming Wu China · #5,934,171 worldwide 241 citations · 39 works
All ranked researchers at HEC Pharm (China)

What are the most cited papers from HEC Pharm (China)?

The most cited paper from HEC Pharm (China) is "Crack-free single-crystal LiNi0.83Co0.10Mn0.07O2 as cycling/thermal stable cathode materials for high-voltage lithium-ion batteries" (Peipei Pang, Xinxin Tan, Zheng Wang et al., 2020), with 151 citations. Next come "A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis" (139) and "Metformin Protects against Oxidative Stress Injury Induced by Ischemia/Reperfusion via Regulation of the lncRNA-H19/miR-148a-3p/Rock2 Axis" (137).

Most cited papers
#PaperReleasedCitations
1 Crack-free single-crystal LiNi0.83Co0.10Mn0.07O2 as cycling/thermal stable cathode materials for high-voltage lithium-ion batteries Peipei Pang, Xinxin Tan, Zheng Wang et al. · Electrochimica Acta 30 Oct 2020 151
2 A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis Qi Pan, Shushan Lin, Yu Li et al. · EBioMedicine Open access 2021 139
3 Metformin Protects against Oxidative Stress Injury Induced by Ischemia/Reperfusion via Regulation of the lncRNA-H19/miR-148a-3p/Rock2 Axis Jing Zeng, Long Zhu, Jing Liu et al. · Oxidative Medicine and Cellular Longevity Open access 17 Dec 2019 137
4 Improving the Solubility and Bioavailability of Apixaban via Apixaban–Oxalic Acid Cocrystal Yong Chen, Long Li, Jia Yao et al. · Crystal Growth & Design 31 Mar 2016 131
5 Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly Guoyi Wu, Bo Liu, Yingjun Zhang et al. · Antimicrobial Agents and Chemotherapy Open access 19 Aug 2013 125
All 61 most cited papers, with filters and sorting

Which keywords describe research at HEC Pharm (China)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Oxidative Stress, Cancer, Metabolism, Glycosylation, Antioxidant Activity, Liquid Chromatography, Type 2 Diabetes and Insulin Resistance.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Oxidative Stress3▲ 4.3×14 topics
  2. Cancer3▲ 4.8×14 topics
  3. Inflammation2▲ 2.4×17 topics
  4. Antioxidant Activity2▲ 7.4×10 topics
  5. Glycosylation2▲ 41×3 topics
  6. Metabolism2▲ 8.6×8 topics
  7. Liquid Chromatography2▲ 67×2 topics
  8. Insulin Resistance2▲ 8.6×7 topics
  9. Type 2 Diabetes2▲ 18×4 topics
  10. Green Analytical Chemistry2▲ 64×2 topics
  11. Medicinal Chemistry2▲ 14×8 topics
  12. Method Validation2▲ 65×2 topics
  13. Antioxidant2▲ 5.0×12 topics
  14. Metabolic Syndrome2▲ 4.4×6 topics
  15. Cancer Prevention2▲ 12×4 topics
  16. Anti-inflammatory1▲ 10×11 topics
  17. Cancer Therapy1▲ 5.2×5 topics
  18. Chiral Separation1▲ 71×1 topic
  19. Gas Chromatography1▲ 71×1 topic
  20. Monoclonal Antibodies1▲ 34×3 topics
  21. Pharmacokinetics1▲ 12×6 topics
  22. Heart Failure1▲ 6.4×3 topics
  23. Mass Spectrometry1▲ 19×4 topics
  24. Reactive Oxygen Species1▲ 7.0×4 topics
  25. Transcriptional Regulation1▲ 17×5 topics
  26. Clinical Guidelines1▲ 8.7×2 topics
  27. Cognitive Function1▲ 14×2 topics
  28. Glycemic Control1▲ 16×2 topics
  29. Insulin Therapy1▲ 20×2 topics
  30. Pharmaceutical Analysis1▲ 140×1 topic
  31. Pharmacological Effects1▲ 40×4 topics
  32. Schizophrenia1▲ 23×2 topics
  33. Therapeutic Antibodies1▲ 38×2 topics
  34. Validation1▲ 28×1 topic
  35. Antibody Engineering1▲ 44×1 topic
  36. Anticancer1▲ 14×7 topics
  37. Cardiovascular Outcomes1▲ 41×1 topic
  38. Fc Receptors1▲ 44×1 topic
  39. Flavonoids1▲ 9.2×4 topics
  40. Glucose Control1▲ 41×1 topic

Which research topics does HEC Pharm (China) publish most on?

By volume in 2022-now: Analytical Chemistry and Chromatography, Analytical Methods in Pharmaceuticals, Monoclonal and Polyclonal Antibodies Research and Diabetes Treatment and Management.

Analytical Chemistry and…1Analytical Chemistry and Chromatography: 1 fractional worksAnalytical Methods in Ph…1Analytical Methods in Pharmaceuticals: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksDiabetes Treatment and M…1Diabetes Treatment and Management: 1 fractional worksGlycosylation and Glycoproteins Research: 1 fractional worksLiver Disease Diagnosis and Treatment: 1 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksNicotinic Acetylcholine Receptors Study: 1 fractional worksProtein Degradation and …1Protein Degradation and Inhibitors: 1 fractional works
SpectroscopyAnalytical ChemistryRadiology, Nuclear Medicine and ImagingEndocrinology, Diabetes and Metabolism3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Analytical Chemistry and Chromatography Spectroscopy 1 works
  2. 2 Analytical Methods in Pharmaceuticals Analytical Chemistry 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  5. 5 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  6. 6 Liver Disease Diagnosis and Treatment Epidemiology 1 works
  7. 7 HER2/EGFR in Cancer Research Oncology 1 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 1 works
  9. 9 Nicotinic Acetylcholine Receptors Study Molecular Biology 1 works
  10. 10 Protein Degradation and Inhibitors Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.5%not open69.5%

World: 40% of research is openly available.

with international co-authors9.7%domestic only90.3%

World: 18% is written across borders.

How has HEC Pharm (China)'s research output changed?

Output in 2022-2025 was 24% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is HEC Pharm (China) as a percentage of every work published that year, 0.00018% in 2024.

still counting0.00010%0.00020%0.00030%HEC Pharm (China)0.00017% in 20252020

Fractional works of HEC Pharm (China) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Dongguan

All research institutions in Dongguan

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about HEC Pharm (China). Posts are plain text and can be reported.